Tykerb Homepage TYKERB is indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 and who have received prior therapy including an anthracycline, a taxane, and trastuzumab. Fdaapprovedbreastcancertherapy.com~Site InfoWhoisTrace RouteRBL Check